Valiant Organics' Stock Performance Declines Amidst Pharmaceutical Sector Downturn

Valiant Organics, a smallcap pharmaceutical company, has been facing a downward trend in its stock performance. On March 13, 2024, the company's stock lost -7.11%, underperforming the sector by -4.94%. This has led to a 'Strong Sell' call by MarketsMOJO.

The stock has been on a consecutive fall for the last four days, with a total decline of -14.42% during this period. On the same day, the stock reached an intraday high of Rs 429.75 (2.09%) and a low of Rs 391 (-7.11%). The high volatility of 5.89% has been calculated from the weighted average price.

Valiant Organics is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a downward trend in its stock price. The pharmaceutical sector as a whole has also seen a decline of -2.33%.

In comparison to the Sensex, Valiant Organics' stock performance has been -4.72% in the last day and -10.96% in the last month, while the Sensex has seen a decline of -1.23% and an increase of 1.69%, respectively.

Despite the company's size as a smallcap, its stock performance has been affected by the overall trend in the pharmaceutical industry. Investors should carefully consider their options before making any decisions regarding Valiant Organics' stock.